Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,800
Closed -$52K 7484
2020
Q3
$52K Sell
1,800
-1,400
-44% -$44K ﹤0.01% 5575
2020
Q2
$114K Buy
3,200
+3,100
+3,100% +$131K ﹤0.01% 5473
2020
Q1
$5K Sell
100
-100
-50% -$4.8K ﹤0.01% 7266
2019
Q4
$14K Sell
200
-2,900
-94% -$182K ﹤0.01% 7084
2019
Q3
$149K Sell
3,100
-12,000
-79% -$626K ﹤0.01% 5386
2019
Q2
$1.01M Sell
15,100
-1,500
-9% -$114K ﹤0.01% 3621
2019
Q1
$1.58M Buy
16,600
+9,600
+137% +$1.2M ﹤0.01% 2917
2018
Q4
$869K Buy
7,000
+5,100
+268% +$840K ﹤0.01% 3542
2018
Q3
$464K Buy
+1,900
New +$439K ﹤0.01% 4375

Other funds holding INGN

Citigroup's INGN Position: Q2 2026 in Review

Citigroup increased its Inogen (INGN) stake by 935% in Q2 2026, buying an estimated $68.3K and bringing the position to 11,422 shares worth $73.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4841.

Citigroup first reported a position in INGN in Q1 2014 and has held it in 50 quarters since. The position peaked at $4.66M in Q2 2019. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Citigroup held 11,422 shares of Inogen worth $73.7K as of Q2 2026.
  • Citigroup bought 10,318 Inogen shares in Q2 2026, an estimated $68.3K.
  • Inogen made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4841 holding.
  • Citigroup first reported a position in Inogen in Q1 2014 and has held it in 50 quarters since.
  • Citigroup's Inogen position peaked at $4.66M in Q2 2019.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.